1887
Preview this article:
Zoom in
Zoomout

The pneumococcus: ‘old man's friend’ and children's foe, Page 1 of 1

| /docserver/preview/fulltext/micro/152/2/281-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.28713-0
2006-02-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/micro/152/2/281.html?itemId=/content/journal/micro/10.1099/mic.0.28713-0&mimeType=html&fmt=ahah

References

  1. Bergmann, S. & Hammerschmidt, S. ( 2006; ). Versatility of pneumococcal surface proteins. Microbiology 152, 295–303.[CrossRef]
    [Google Scholar]
  2. Bogaert, D., van Belkum, A., Sluijter, M., Luijendijk, A., van Groot, R., Rumke, H. C., Verbrugh, H. A. & Hermans, P. W. ( 2004; ). Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363, 1871–1872.[CrossRef]
    [Google Scholar]
  3. Guiral, S., Henard, V., Granadel, C., Martin, B. & Claverys, J.-P. ( 2006a; ). Inhibition of competence development in Streptococcus pneumoniae by increased basal-level expression of the ComDE two-component regulatory system. Microbiology 152, 323–331.[CrossRef]
    [Google Scholar]
  4. Guiral, S., Hénard, V., Laaberki, M.-H., Granadel, C., Prudhomme, M., Martin, B. & Claverys, J.-P. ( 2006b; ). Construction and evaluation of a chromosomal expression platform (CEP) for ectopic, maltose-driven gene expression in Streptococcus pneumoniae. Microbiology 152, 343–349.[CrossRef]
    [Google Scholar]
  5. Håvarstein, L. S., Coomaraswamy, G. & Morrison, D. A. ( 1995; ). An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad Sci U S A 92, 11140–11144.[CrossRef]
    [Google Scholar]
  6. Hicks, L. A., Flannery, B. L., Beall, B. W. & 12 other authors ( 2005; ). Replacement pneumococcal disease: increase in non-vaccine type disease in the era of widespread pneumococcal conjugate vaccination. Infectious Disease Society of America 43rd Annual Meeting, San Francisco, abstract 978. Alexandria, VA: Infectious Diseases Society of America.
  7. Kloosterman, T. G., Bijlsma, J. J. E., Kok, J. & Kuipers, O. P. ( 2006; ). To have a neighbour's fare: extending the molecular toolbox for Streptococcus pneumoniae. Microbiology 152, 351–359.[CrossRef]
    [Google Scholar]
  8. Klugman, K. P. ( 2001; ). Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis 1, 85–91.[CrossRef]
    [Google Scholar]
  9. LeMessurier, K. L., Ogunniyi, A. D. & Paton, J. C. ( 2006; ). Differential expression of key pneumococcal virulence genes in vivo. Microbiology 152, 305–311.[CrossRef]
    [Google Scholar]
  10. Lysenko, E. S., Ratner, A. J., Nelson, A. L. & Weiser, J. N. ( 2005; ). The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PloS Pathog 1, el. Epub 2005 Jul 22. http://dx.doi.org/10.1371/journal.ppat.0010001
    [Google Scholar]
  11. McIntosh, E. D. ( 2003; ). How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine? Arch Dis Child 88, 859–861.[CrossRef]
    [Google Scholar]
  12. Romao, S., Memmi, G., Oggioni, M. R. & Trombe, M.-C. ( 2006; ). LuxS impacts on LytA-dependent autolysis and on competence in Streptococcus pneumoniae. Microbiology 152, 333–341.[CrossRef]
    [Google Scholar]
  13. Tettelin, H., Nelson, K. E., Paulsen, I. T., & 36 others ( 2001; ). Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498–506.[CrossRef]
    [Google Scholar]
  14. Veenhoven, R. H., Bogaert, D., Schilder, A. G. & 11 other authors (2004; ). Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media. Clin Infect Dis 39, 911–919.[CrossRef]
    [Google Scholar]
  15. Whitney, C. G., Farley, M. M., Hadler, J. & 10 other authors ( 2003; ). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348, 1737–1746.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.28713-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error